On the filings, Universal Health (UHS) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it BUY.
Cheap at its multiple: durable hospital cash machine compounding EPS through buybacks — debt-funded, not distressed.
A 6x-earnings hospital operator firing on all cylinders — the discount is Medicaid policy risk that doesn't bite until 2028.
| Metric | HCA | UHS |
|---|---|---|
| Fundamentals score | 61 | 79 |
| Revenue growth (YoY) | +7.1% | +9.7% |
| Net income growth (YoY) | +17.8% | +30.4% |
| Net margin | 9.0% | 8.6% |
| Return on equity | — | 20.5% |
| ROIC (est.) | — | 13.1% |
| Liabilities / Equity | -7.57 | — |
| Piotroski F-score | 6 / 9 | 7 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 11:13 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:52 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.